Pharmacokinetics and bioavailability of rhIGF-I/IGFBP-3 in the rat and monkey
- 31 December 1995
- journal article
- Published by Elsevier BV in Progress in Growth Factor Research
- Vol. 6 (2-4), 347-356
- https://doi.org/10.1016/0955-2235(95)00003-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Systemic administration of rhIGF-I or rhIGF-I/IGFBP-3 increases cortical bone and lean body mass in ovariectomized ratsBone, 1995
- Intravenously injected insulin-like growth factor (IGF) I/IGF binding protein-3 complex exerts insulin-like effects in hypophysectomized, but not in normal rats.JCI Insight, 1995
- Benefit of systemically administered rhIGF-I and rhIGF-I/IGFBP-3 on cancellous bone in ovariectomized ratsJournal of Bone and Mineral Research, 1994
- Recombinant Human Growth Hormone Accelerates Wound Healing in Children with Large Cutaneous BurnsAnnals of Surgery, 1994
- Purification and characterization of the acid-labile subunit of rat serum insulin-like growth factor binding protein complexEndocrinology, 1994
- Insulin‐like growth factor‐l blood levels in severely burned patients: effects of time post injury, age of patient and severity of burnClinical Endocrinology, 1993
- Insulin-like growth factor 1 (IGF-1) in burn patientsBurns, 1991
- Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin–like growth factor‐IClinical Endocrinology, 1991
- Effects of Recombinant Human Growth Hormone on Donor-site Healing in Severely Burned ChildrenAnnals of Surgery, 1990
- Short-Term Metabolic Effects of Recombinant Human Insulin-like Growth Factor I in Healthy AdultsThe New England Journal of Medicine, 1987